tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Albert Lowe, 10 are a BUY (100%).
Analyst Albert Lowe, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 16.67% that have a potential upside of 11.5% achieved within 42 days.
Albert Lowe’s has documented 20 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PMVP, Pmv Pharmaceuticals at 12-Nov-2025.
Analyst best performing recommendations are on ATOS (ATOSSA GENETICS).
The best stock recommendation documented was for ATOS (ATOSSA GENETICS) at 6/5/2025. The price target of $4 was fulfilled within 252 days with a profit of $8.9 (68.99%) receiving and performance score of 2.74.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Sep-2020
$24
$22.12 (1176.60%)
$8
3 months 1 days ago
(10-Apr-2026)
11/12 (91.67%)
$19.06 (385.83%)
526
Buy Since 12-Feb-2024
$25
$23.12 (1229.79%)
$7
3 months 15 days ago
(26-Mar-2026)
14/15 (93.33%)
$20.29 (430.79%)
444
Buy Since 05-Jun-2025
$4
$2.12 (112.77%)
1 years 1 months 6 days ago
(05-Jun-2025)
1/1 (100%)
$-8.9 (-68.99%)
252
Buy Since 08-Sep-2023
2 years 21 days ago
(20-Jun-2024)
1/1 (100%)
$-7.5 (-60.00%)
885
Buy Since 11-Oct-2018
$7
$2.06 (41.70%)
5 years 1 months 1 days ago
(10-Jun-2021)
4/4 (100%)
$-54.05 (-88.53%)
1656
What Year was the first public recommendation made by Albert Lowe?
